⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
🧸 Product LT January 24, 2025

BIOSILK — SILK Therapy LITE

Liquid hair oil, leave-in hair care product, 15 ml.

📷 Safety Gate / European Commission · Source
Additional photo
BIOSILK — SILK Therapy LITE
📷 Safety Gate / European Commission · Source
Risk level
Serious risk
Type
Chemical
Category
Cosmetics
Hazard
According to the list of ingredients, the product contains octamethylcyclotetrasiloxane (D4), which is prohibited in leave-on cosmetics. D4 may damage reproductive health.
Origin
Slovenia

⚖️ Actions ordered by authorities

  • ▸ (to: Retailer) Withdrawal of the product from market
Barcode (GTIN): 6339117452810
🗄
Archived (older alert)
This alert was reported 488 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
10 days in total
May 17, 2026 May 27, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? This is a hair product called BIOSILK — SILK Therapy LITE. It contains a chemical called octamethylcyclotetrasiloxane (D4).

What's happening? The product has D4, which is not allowed in leave-on cosmetics. D4 may harm reproductive health.

Does this affect me? If you used this product in Lithuania, you may be at risk.

What should I do? Stop using the product. Ask your pharmacist or doctor if you have concerns.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Brand(s) / product name(s)
BIOSILK
Agency-published detail

Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: According to the list of ingredients, the product contains octamethylcyclotetrasiloxane (D4), which is prohibited in leave-on cosmetics. D4 may damage reproductive health. · Origin: Slovenia

First published
January 24, 2025
Last refreshed by us
1 week ago
Severity (as classified)
High
Official source
https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10092675

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this product recall alert about?
BIOSILK — SILK Therapy LITE. Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: According to the list of ingredients, the product contains octamethylcyclotetrasiloxane (D4), which is prohibited in leave-on cosmetics. D4 may damage reproductive health. · Origin: Slovenia
▸ When was this alert issued?
This alert was issued on January 24, 2025 by EU Safety Gate.
▸ Which countries are affected?
The alert applies to Lithuania.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you have this product at home, stop using it and return it to the point of purchase for a refund. Keep the receipt if you have one — most retailers refund without it for safety recalls.
▸ Where can I find the official notice?
The full official notice is published on ec.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.